Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,145.60
+23.95 (2.14%)
At close: Jan 22, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 665.19 billion as of January 23, 2026. Its market cap has decreased by -13.20% in one year.
Market Cap
665.19B
Enterprise Value
654.14B
Revenue
325.14B
Ranking
n/a
PE Ratio
19.44
Stock Price
1,145.60
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 665.19B, an increase of 6,826.72%. That is a compound annual growth rate of 19.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 665.19B | -3.19% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 19.13T |
| HDFC Bank | 14.33T |
| Bharti Airtel | 12.07T |
| Tata Consultancy Services | 11.22T |
| ICICI Bank | 9.84T |
| State Bank of India | 9.59T |
| Infosys | 6.71T |
| Hindustan Unilever | 6.24T |